Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA)

J. Kavanagh (London, United Kingdom), A. Hearn (London, United Kingdom), C. Roxas (London, United Kingdom), L. Green (London, United Kingdom), M. Fernandes (London, United Kingdom), L. Thomson (London, United Kingdom), V. Payne (London, United Kingdom), G. D'Ancona (London, United Kingdom), B. Kent (Dublin, United Kingdom), J. Dhariwal (London, United Kingdom), A. Nanzer-Kelly (London, United Kingdom), D. Jackson (London, United Kingdom)

Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Kavanagh (London, United Kingdom), A. Hearn (London, United Kingdom), C. Roxas (London, United Kingdom), L. Green (London, United Kingdom), M. Fernandes (London, United Kingdom), L. Thomson (London, United Kingdom), V. Payne (London, United Kingdom), G. D'Ancona (London, United Kingdom), B. Kent (Dublin, United Kingdom), J. Dhariwal (London, United Kingdom), A. Nanzer-Kelly (London, United Kingdom), D. Jackson (London, United Kingdom). Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA). 2253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004

Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO)
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand
Source: Eur Respir J 2001; 18: Suppl. 33, 38s
Year: 2001

Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008


Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR)
Source: Eur Respir J 2004; 24: Suppl. 48, 271s
Year: 2004

Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002

Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Salt chamber treatment had no effect on fractional exhaled nitric oxide (FeNO) in patients with symptoms suggesting asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008

Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006

Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients.
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004